We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
-18.58%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$736M
AUM Growth
-$206M
Cap. Flow
-$15M
Cap. Flow %
-2.04%
Top 10 Hldgs %
41.67%
Holding
172
New
4
Increased
40
Reduced
22
Closed
68

Top Buys

Rank Stock Value
1
TDOC icon
Teladoc Health
TDOC
+$19.6M
2
AERI
Aerie Pharmaceuticals
AERI
+$16.7M
3
GILD icon
Gilead Sciences
GILD
+$11.1M
4
IMMU
Immunomedics Inc
IMMU
+$10.5M
5
CELG
Celgene Corp
CELG
+$8.56M

Top Sells

Rank Stock Value
1
KTWO
K2M Group Holdings, Inc
KTWO
+$24.8M
2
JNJ icon
Johnson & Johnson
JNJ
+$16.9M
3
COLL icon
Collegium Pharmaceutical
COLL
+$14.2M
4
CLVS
Clovis Oncology, Inc.
CLVS
+$13M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$12.3M

Sector Composition

Rank Sector Weight
1 Healthcare 81.78%
2 Technology 1.41%
3 Industrials 1.2%
4 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SYK icon
76
Stryker
SYK
$135B
$324K 0.04%
2,066
– –
CERS icon
77
Cerus
CERS
$575M
$307K 0.04%
60,576
– –
DERM
78
DELISTED
Dermira, Inc.
DERM
$301K 0.04%
41,902
– –
ZLAB icon
79
Zai Lab
ZLAB
$2.07B
$292K 0.04%
12,589
-32,379
-72% -$601K
CHRS icon
80
Coherus Oncology
CHRS
$217M
$253K 0.03%
27,987
– –
CNC icon
81
Centene
CNC
$30.5B
$240K 0.03%
4,160
-20
-0.5% -$1.34K
KANG
82
DELISTED
iKang Healthcare Group, Inc.
KANG
$235K 0.03%
11,513
– –
BPMC
83
DELISTED
Blueprint Medicines
BPMC
$226K 0.03%
4,184
– –
RVNC
84
DELISTED
Revance Therapeutics, Inc.
RVNC
$226K 0.03%
11,234
– –
ZBH icon
85
Zimmer Biomet
ZBH
$18.8B
$218K 0.03%
2,162
– –
CCXI
86
DELISTED
ChemoCentryx, Inc.
CCXI
$194K 0.03%
17,811
– –
TLPH icon
87
Talphera
TLPH
$68M
$170K 0.02%
3,689
– –
KURA icon
88
Kura Oncology
KURA
$793M
$166K 0.02%
11,800
– –
CTMX icon
89
CytomX Therapeutics
CTMX
$690M
$152K 0.02%
10,058
– –
ATRS
90
DELISTED
Antares Pharma, Inc.
ATRS
$129K 0.02%
47,280
– –
LITS
91
Lite Strategy Inc
LITS
$32.4M
$118K 0.02%
2,227
– –
QTNT
92
DELISTED
Quotient Limited Ordinary Shares
QTNT
$108K 0.01%
441
– –
CYTK icon
93
Cytokinetics
CYTK
$10.6B
$98K 0.01%
15,582
– –
SYRE icon
94
Spyre Therapeutics
SYRE
$8.5B
$97K 0.01%
518
– –
ABEO icon
95
Abeona Therapeutics
ABEO
$355M
$91K 0.01%
507
– –
BLRX
96
BioLineRX
BLRX
$12M
$87K 0.01%
330
– –
PTGX icon
97
Protagonist Therapeutics
PTGX
$8.55B
$77K 0.01%
+11,400
New +$90.4K
CDTX
98
DELISTED
Cidara Therapeutics
CDTX
$60K 0.01%
1,272
– –
NBRV
99
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$56K 0.01%
153
– –
MRNS
100
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$48K 0.01%
4,200
– –
2 3
4
5 6

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q4 2018 Portfolio in Review

As of Q4 2018, Sectoral Asset Management held 172 positions worth $736M, down 22% from $942M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Sectoral Asset Management's Q4 2018 filing shows 4 new, 40 increased, 22 reduced and 68 closed positions. Its largest new stake was Kineta, Inc. Common Stock: 11,298 shares worth $5.13M. The largest sale was K2M Group Holdings, Inc, an estimated $24.8M.

By sector, the portfolio is most concentrated in Healthcare at 82% of assets, down from 85% a quarter earlier, followed by Technology and Industrials.

  • Sectoral Asset Management's largest Q4 2018 buy was Kineta, Inc. Common Stock: 11,298 shares worth $5.13M.
  • Sectoral Asset Management added most to Teladoc Health in Q4 2018, an estimated $19.6M increase.
  • Sectoral Asset Management's biggest Q4 2018 reduction was Johnson & Johnson, cutting an estimated $16.9M.
  • Sectoral Asset Management fully exited K2M Group Holdings, Inc in Q4 2018, selling an estimated $24.8M.
  • Sectoral Asset Management's ten largest holdings make up 42% of its $736M portfolio in Q4 2018.
  • Sectoral Asset Management opened 4 new positions and closed 68 in Q4 2018.
  • Sectoral Asset Management's portfolio value fell 22% quarter-over-quarter to $736M.

Based on Sectoral Asset Management's 13F filing for Q4 2018, filed 12 Feb 2019.